Integra LifeSciences Holdings Long Term Debt 2010-2023 | IART

Integra LifeSciences Holdings long term debt from 2010 to 2023. Long term debt can be defined as the sum of all long term debt fields.
Integra LifeSciences Holdings Annual Long Term Debt
(Millions of US $)
2023 $1,485
2022 $1,405
2021 $1,501
2020 $1,408
2019 $1,303
2018 $1,332
2017 $1,781
2016 $665
2015 $700
2014 $626
2013 $392
2012 $520
2011 $532
2010 $295
2009 $309
Integra LifeSciences Holdings Quarterly Long Term Debt
(Millions of US $)
2023-12-31 $1,485
2023-09-30 $1,420
2023-06-30 $1,333
2023-03-31 $1,440
2022-12-31 $1,405
2022-09-30 $1,487
2022-06-30 $1,498
2022-03-31 $1,502
2021-12-31 $1,501
2021-09-30 $1,499
2021-06-30 $1,499
2021-03-31 $1,485
2020-12-31 $1,408
2020-09-30 $1,506
2020-06-30 $1,541
2020-03-31 $1,577
2019-12-31 $1,303
2019-09-30 $1,384
2019-06-30 $1,307
2019-03-31 $1,331
2018-12-31 $1,332
2018-09-30 $1,421
2018-06-30 $1,476
2018-03-31 $1,772
2017-12-31 $1,781
2017-09-30 $1,153
2017-06-30 $868
2017-03-31 $849
2016-12-31 $665
2016-09-30 $659
2016-06-30 $684
2016-03-31 $712
2015-12-31 $700
2015-09-30 $719
2015-06-30 $644
2015-03-31 $611
2014-12-31 $626
2014-09-30 $621
2014-06-30 $631
2014-03-31 $629
2013-12-31 $392
2013-09-30 $545
2013-06-30 $543
2013-03-31 $521
2012-12-31 $520
2012-09-30 $518
2012-06-30 $516
2012-03-31 $523
2011-12-31 $532
2011-09-30 $542
2011-06-30 $490
2011-03-31 $294
2010-12-31 $295
2010-09-30 $366
2010-06-30 $372
2010-03-31 $295
2009-12-31 $309
2009-09-30 $307
2009-06-30 $306
2009-03-31 $431
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $2.501B $1.542B
Integra LifeSciences is one of the world leaders in regenerative medicine. The company develops, manufactures and markets cost-effective surgical implants and medical instruments. The company now manufactures and sells products in the following two global reportable business segments: Codman Specialty Surgical (CSS) and Orthopedics and Tissue Technologies (OTT). The CSS business offers global, market-leading technologies, brands and instrumentation. The global commercial network includes clinical specialists, a large direct global sales force and strategic partnerships and distributors that serve hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers and health care providers in North America, South America, Europe, Asia Pacific, Middle East and Africa. The Tissue Technologies segment includes wound reconstruction and repair products, bone grafts and nerve and tendon repair products.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $211.679B 25.75
Intuitive Surgical (ISRG) United States $134.177B 83.75
Edwards Lifesciences (EW) United States $54.204B 35.88
DexCom (DXCM) United States $52.631B 90.41
IQVIA Holdings (IQV) United States $41.589B 24.67
IDEXX Laboratories (IDXX) United States $40.661B 48.62
Alcon (ALC) Switzerland $39.256B 28.95
STERIS (STE) Ireland $19.665B 23.28
Waters (WAT) United States $18.607B 26.70
Hologic (HOLX) United States $17.631B 19.46
SONOVA HOLDING (SONVY) Switzerland $16.535B 0.00
ShockWave Medical (SWAV) United States $12.247B 84.62
Fresenius Medical Care AG KGaA (FMS) Germany $10.915B 13.48
Sysmex ADR (SSMXY) Japan $9.988B 31.32
Teleflex (TFX) United States $9.896B 15.54
Penumbra (PEN) United States $8.130B 100.50
Masimo (MASI) United States $7.312B 41.00
Globus Medical (GMED) United States $7.011B 22.23
Glaukos (GKOS) United States $4.796B 0.00
Integer Holdings (ITGR) United States $3.997B 25.55
TransMedics (TMDX) United States $3.052B 0.00
LivaNova (LIVN) United Kingdom $2.869B 18.92
Elekta AB (EKTAY) Sweden $2.673B 18.34
PROCEPT BioRobotics (PRCT) United States $2.650B 0.00
Nihon Kohden (NHNKY) Japan $2.368B 20.03
Inari Medical (NARI) United States $2.266B 391.00
Tandem Diabetes Care (TNDM) United States $2.128B 0.00
RxSight (RXST) United States $2.009B 0.00
Alphatec Holdings (ATEC) United States $1.820B 0.00
Veracyte (VCYT) United States $1.420B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.862B 15.94
OPKO Health (OPK) United States $0.843B 0.00
Artivion (AORT) United States $0.837B 96.71
Paragon 28 (FNA) United States $0.799B 0.00
OrthoPediatrics (KIDS) United States $0.718B 0.00
Treace Medical Concepts (TMCI) United States $0.712B 0.00
Silk Road Medical (SILK) United States $0.694B 0.00
SiBone (SIBN) United States $0.630B 0.00
Mesa Laboratories (MLAB) United States $0.553B 18.77
IRadimed (IRMD) United States $0.520B 30.17
ORTHOFIX MEDICAL INC (OFIX) United States $0.493B 0.00
Nevro (NVRO) United States $0.466B 0.00
Pulse Biosciences (PLSE) United States $0.430B 0.00
Pacific Biosciences Of California (PACB) United States $0.375B 0.00
NeuroPace (NPCE) United States $0.369B 0.00
CVRx (CVRX) United States $0.354B 0.00
Tactile Systems Technology (TCMD) United States $0.342B 11.50
AxoGen (AXGN) United States $0.306B 0.00
EDAP TMS S.A (EDAP) France $0.271B 0.00
AngioDynamics (ANGO) United States $0.261B 0.00
Sight Sciences (SGHT) United States $0.259B 0.00
Accuray (ARAY) United States $0.221B 0.00
Atossa Genetics (ATOS) United States $0.193B 0.00
908 Devices (MASS) United States $0.191B 0.00
Alpha Tau Medical (DRTS) Israel $0.190B 0.00
Semler Scientific (SMLR) United States $0.183B 9.84
Inogen (INGN) United States $0.162B 0.00
ClearPoint Neuro (CLPT) United States $0.151B 0.00
Neuronetics (STIM) United States $0.121B 0.00
Delcath Systems (DCTH) United States $0.120B 0.00
Envoy Medical (COCH) United States $0.117B 0.00
Yubo Biotech (YBGJ) China $0.112B 0.00
KORU Medical Systems (KRMD) United States $0.098B 0.00
Spectral Diagnostics (EDTXF) Canada $0.090B 0.00
Monogram Orthopaedics (MGRM) United States $0.083B 0.00
Hyperfine (HYPR) United States $0.071B 0.00
EnVVeno Medical (NVNO) United States $0.063B 0.00
SEP Acquisition (SEPA) United States $0.058B 0.00
Vasomedical (VASO) United States $0.057B 10.32
InspireMD (NSPR) Israel $0.053B 0.00
Sensus Healthcare (SRTS) United States $0.052B 106.67
Autonomix Medical (AMIX) United States $0.052B 0.00
Vicarious Surgical (RBOT) United States $0.052B 0.00
Aspira Women's Health (AWH) United States $0.043B 0.00
ReWalk Robotics (LFWD) Israel $0.042B 0.00
Rapid Micro Biosystems (RPID) United States $0.040B 0.00
Lucid Diagnostics (LUCD) United States $0.039B 0.00
Pixie Dust Technologies (PXDT) Japan $0.038B 0.00
Spectral AI (MDAI) United States $0.035B 0.00
DarioHealth (DRIO) United States $0.034B 0.00
LENSAR (LNSR) United States $0.034B 0.00
Precision Optics (POCI) United States $0.033B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.024B 0.00
Ekso Bionics Holdings (EKSO) United States $0.024B 0.00
QT Imaging Holdings (QTI) United States $0.018B 0.00
Accelerate Diagnostics (AXDX) United States $0.018B 0.00
PAVmed (PAVM) United States $0.017B 0.00
T2 Biosystems (TTOO) United States $0.017B 0.00
Microbot Medical (MBOT) United States $0.014B 0.00
Biosig Technologies (BSGM) United States $0.014B 0.00
NexGel (NXGL) United States $0.013B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
Avinger (AVGR) United States $0.006B 0.00
Venus Concept (VERO) Canada $0.005B 0.00
Helius Medical Technologies (HSDT) United States $0.005B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.003B 0.00
Dynatronics (DYNT) United States $0.003B 0.00
Nuwellis (NUWE) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
ReShape Lifesciences (RSLS) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00